SII cervical cancer vaccine to be available in market this month at Rs 2000 for two doses Roshni Dhar10 Feb 2023 6:00 PM ISTThe Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per...
Health Bulletin 10/February/2023 Roshni Dhar10 Feb 2023 4:44 PM ISTHere are the top health stories for the day:NMC gives deadline to FMGE June 2023 candidates applying for eligibility certificateReferring to the...
Serum Institute cervical cancer vaccine CERVAVAC to be available in market this month at Rs 2000 for two doses: Sources Ruchika Sharma10 Feb 2023 12:15 PM ISTNew Delhi: The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of...
Govt likely to float global tender for HPV vaccine in April; Serum Institute, Merck may participate Ruchika Sharma30 Jan 2023 12:42 PM ISTNew Delhi: The Health Ministry intends to roll out HPV vaccine against cervical cancer in the national immunisation programme for girls aged 9 to...
Cervical cancer vaccine CERVAVAC to be available in small quantity in 2023, increased next year: Adar Poonawalla Ruchika Sharma27 Jan 2023 1:15 PM ISTTalking about the rollout programme of the vaccine, Poonawalla said that it would be done through government programmes this year.
Serum Institute of India unveils first made-in-India HPV vaccine for cervical cancer Roshni Dhar25 Jan 2023 4:40 PM ISTChief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, has announced the launch of the first made-in-India Human Papillomavirus...
Health Bulletin 25/January/2023 Roshni Dhar25 Jan 2023 4:28 PM ISTHere are the top health stories for the day:Serum Institute of India launches first made-in-India HPV vaccine for cervical cancerChief Executive...
MSD bags DCGI nod for Keytruda to treat cervical cancer Ruchika Sharma25 Jan 2023 12:30 PM ISTMumbai: Drugs Controller General of India (DCGI) has approved Keytruda (pembrolizumab), MSD’s anti-PD-1 therapy, for the treatment of persistent,...
SII unveils first made-in-India HPV vaccine for cervical cancer Ruchika Sharma25 Jan 2023 11:15 AM IST'CERVAVAC' is an outcome of a partnership of DBT and BIRAC with the Bill and Melinda Gates Foundation, supported by Serum Institute of India Private...
Proton pump inhibitor use linked to lower risk for female cancers Dr. Shravani Dali19 Jan 2023 8:00 PM ISTProton pump inhibitor use linked to lower risk for female cancers suggests a recent study published in the Cancers.Firm conclusions about whether...
Centre deliberates on HPV vaccine introduction in national immunisation programme next year Ruchika Sharma19 Dec 2022 12:22 PM ISTThe government advisory panel NTAGI has also given its go-ahead for the inclusion of CERVAVAC in the public immunisation programme
SII Cervical cancer vaccine CERVAVAC likely to be launched in April next year Ruchika Sharma15 Dec 2022 1:00 PM ISTSerum Institute's vaccine is likely to be available at a much lower rate.
